FLOWPHYSIX ANNOUNCES STRATEGIC PARTNERSHIP WITH 3COMMA FOR INTERNATIONAL DISTRIBUTION OF INNOVATIVE THROMBECTOMY DEVICE [Yahoo! Finance]
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Yahoo! Finance
PLEASANTON, Calif. Sept. 11, 2024 3comma is an international commercialization agency with deep expertise in building and scaling global revenue streams for early-stage medical device companies. This partnership between FlowPhysix and 3comma will provide physicians outside the United States access to new standards in thrombectomy technology, enabling FlowPhysix to focus on US commercialization 3comma Managing Partner and former Vice President of International at Penumbra, Inc., Marc Paris believes the FLOWRUNNER System will make an immediate impact in the peripheral thrombectomy segment. "We can rapidly activate our established international commercial infrastructure to accelerate adoption of the FLOWRUNNER system. We are confident that FlowPhysix will be the next major disruptor in the global thrombectomy market and we are excited to be part of this endeavor," Paris said. The FLOWRUNNER System overcomes the characteristic vacuum decay that limits conventional aspiration cathet
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $238.00 price target on the stock.MarketBeat
- Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in EuropePR Newswire
- North America Clot Management Devices Market Outlook to 2033 Featuring Boston Scientific, Inari Medical, Medtronic, Penumbra, and Teleflex [Yahoo! Finance]Yahoo! Finance
- Penumbra, Inc. (NYSE: PEN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.MarketBeat
- Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $263.00 price target on the stock.MarketBeat
PEN
Earnings
- 7/30/24 - Beat
PEN
Sec Filings
- 9/5/24 - Form 4
- 9/5/24 - Form 4
- 9/4/24 - Form 144
- PEN's page on the SEC website